{"id":381997,"date":"2020-11-16T11:03:23","date_gmt":"2020-11-16T16:03:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381997"},"modified":"2020-11-16T11:03:23","modified_gmt":"2020-11-16T16:03:23","slug":"teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/","title":{"rendered":"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals"},"content":{"rendered":"
\n

NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication (https:\/\/www.nature.com\/articles\/s42255-020-00298-z<\/a>) of a proof of concept study by the Chini Laboratory (Mayo Clinic\u2019s campus in Rochester, Minnesota) describing the rejuvenation of energy metabolism in aged mice undergoing therapy with Teneobio\u2019s CD38 blocker.<\/p>\n

The presented findings demonstrate that chronic inflammation (\u201cinflammaging\u201d) mediated by senescent cells induces a CD38-mediated decline in precursors involved in cellular health and energy metabolism. Specific inhibition of CD38 using Teneobio\u2019s CD38 specific antibody raised levels of these precursors and restored nicotinamide nucleotide homeostasis in aged animals.<\/p>\n

Wim van Schooten, Chief Scientific Officer at Teneobio, said, \u201cBoosting NAD+ levels and Sirtuin activity are known for their strong anti-inflammatory and tissue protective effects. Repair of inflammation-related decline of NAD+ could be an effective therapy of aging -associated diseases such as fibrosis and metabolic disorders. Teneobio plans to initiate clinical trials with this exciting new anti-CD38 therapeutic in the first half of 2021.\u201d<\/p>\n

\n About <\/strong>
\n Teneobio<\/strong>
\n , Inc.<\/strong>\n <\/p>\n

Teneobio, Inc. is a clinical stage biotechnology company developing a new class of biologics, Human Heavy-Chain Antibodies (UniAb\u00ae), for the treatments of cancer, autoimmunity, and infectious diseases. Teneobio\u2019s discovery platform, TeneoSeek, comprises genetically engineered animals (UniRat\u00ae and OmniFlic\u00ae), next-generation sequencing, bioinformatics and high-throughput vector assembly technologies. TeneoSeek rapidly identifies large numbers of unique binding molecules specific for therapeutic targets of interest. Versatile antibody variable domains (UniDab\u00ae) derived from UniAb\u00ae can be assembled into multi-specific and multivalent therapeutic proteins, surpassing limitations of conventional antibody therapeutics. Teneobio\u2019s \u201cplug-and-play\u201d heavy chain antibody platform includes a diverse set of immunomodulatory antibodies for therapeutics with optimal efficacy and reduced toxicity.<\/p>\n

Teneobio partners include AbbVie, Janssen, GSK, Kite and Poseida, Intellia and ArsenalBio.\u00a0 For more information, please visit www.teneobio.com<\/a>.<\/p>\n

\n About TeneoFour, Inc.<\/strong>\n <\/p>\n

TeneoFour, Inc. is a spinout of Teneobio, Inc. developing anti-CD38 heavy chain antibodies that block the enzyme functions of CD38. TeneoFour, Inc. owns all rights to products and intellectual property generated at Teneobio, Inc. regarding human heavy chain antibodies specific for CD38.<\/p>\n

\n Company Inquiries for <\/strong>
\n Teneobio<\/strong>
\n , Inc.<\/strong>
\n and TeneoFour, Inc.<\/strong>
\n
Omid Vafa, Chief Business Officer
ovafa@teneobio.com<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication (https:\/\/www.nature.com\/articles\/s42255-020-00298-z) of a proof of concept study by the Chini Laboratory (Mayo Clinic\u2019s campus in Rochester, Minnesota) describing the rejuvenation of energy metabolism in aged mice undergoing therapy with Teneobio\u2019s CD38 blocker. The presented findings demonstrate that chronic inflammation (\u201cinflammaging\u201d) mediated by senescent cells induces a CD38-mediated decline in precursors involved in cellular health and energy metabolism. Specific inhibition of CD38 using Teneobio\u2019s CD38 specific antibody raised levels of these precursors and restored nicotinamide nucleotide homeostasis in aged animals. Wim van Schooten, Chief Scientific Officer at Teneobio, said, \u201cBoosting NAD+ levels and Sirtuin activity are known for their strong … <\/p>\n

Continue reading “TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381997","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication (https:\/\/www.nature.com\/articles\/s42255-020-00298-z) of a proof of concept study by the Chini Laboratory (Mayo Clinic\u2019s campus in Rochester, Minnesota) describing the rejuvenation of energy metabolism in aged mice undergoing therapy with Teneobio\u2019s CD38 blocker. The presented findings demonstrate that chronic inflammation (\u201cinflammaging\u201d) mediated by senescent cells induces a CD38-mediated decline in precursors involved in cellular health and energy metabolism. Specific inhibition of CD38 using Teneobio\u2019s CD38 specific antibody raised levels of these precursors and restored nicotinamide nucleotide homeostasis in aged animals. Wim van Schooten, Chief Scientific Officer at Teneobio, said, \u201cBoosting NAD+ levels and Sirtuin activity are known for their strong … Continue reading "TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-16T16:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals\",\"datePublished\":\"2020-11-16T16:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/\"},\"wordCount\":373,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/\",\"name\":\"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=\",\"datePublished\":\"2020-11-16T16:03:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/","og_locale":"en_US","og_type":"article","og_title":"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals - Market Newsdesk","og_description":"NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication (https:\/\/www.nature.com\/articles\/s42255-020-00298-z) of a proof of concept study by the Chini Laboratory (Mayo Clinic\u2019s campus in Rochester, Minnesota) describing the rejuvenation of energy metabolism in aged mice undergoing therapy with Teneobio\u2019s CD38 blocker. The presented findings demonstrate that chronic inflammation (\u201cinflammaging\u201d) mediated by senescent cells induces a CD38-mediated decline in precursors involved in cellular health and energy metabolism. Specific inhibition of CD38 using Teneobio\u2019s CD38 specific antibody raised levels of these precursors and restored nicotinamide nucleotide homeostasis in aged animals. Wim van Schooten, Chief Scientific Officer at Teneobio, said, \u201cBoosting NAD+ levels and Sirtuin activity are known for their strong … Continue reading \"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-16T16:03:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals","datePublished":"2020-11-16T16:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/"},"wordCount":373,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/","name":"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=","datePublished":"2020-11-16T16:03:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NTk1MyMzODI2ODA1IzIwMTk4NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teneofours-cd38-inhibitor-rejuvenates-energy-metabolism-of-aged-animals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TeneoFour\u2019s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381997"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381997\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}